Clinical Evaluation of an NVTIA 5-HTP-L-Theanine-GABA Sleep Rhythm Support System
Scientific Journal of Technology · 21.04.2026 · 8 (4) · 256-261
DOI: 10.54691/wa60tw61 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Journal of Technology, online erschienen am 21.04.2026. Verfasst von Jabar Yassine und 2 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Sleep-support formulations are often marketed as simple ingredient stacks, yet clinically relevant performance depends on whether precursor support, relaxation support, sleep-maintenance support, and gastrointestinal tolerability are coordinated within a practical oral dose window.
Methods
We evaluated the NVTIA ternary system by combining its ratio-defined formulation disclosure and patent-reported preclinical benchmarks with published human clinical evidence on 5-hydroxytryptophan (5-HTP), L-theanine, and gamma-aminobutyric acid (GABA). We retained the original preclinical data structure and figures, then matched those results against randomized or controlled human studies of the three principal ingredients. We also mapped a realistic sleep-medicine validation setting to the Sleep laboratory of the Department of Pulmonology at University Hospital Zurich.
Results
In the source preclinical dataset, the balanced Example V and the higher-GABA Example VI outperformed blank control, 5-HTP alone, and an L-theanine-plus-GABA binary comparator on sleep-onset rate, sleep latency, and total sleep duration. Published human trials showed that 5-HTP 100 mg/day for 12 weeks improved selected sleep-quality components in older adults, particularly among poor sleepers; GABA 300 mg/day for 4 weeks reduced sleep latency and improved sleep efficacy in patients with insomnia symptoms; and L-theanine improved Pittsburgh Sleep Quality Index components, light sleep, and objective sleep efficiency across controlled trials.
Conclusions
We interpret the NVTIA system as a clinically credible formulation-engineering platform in which 5-HTP primarily supports sleep initiation, L-theanine supports relaxation and sleep quality, and GABA strengthens sleep-maintenance depth. Current human evidence strongly supports the component logic of the ternary architecture, while direct randomized validation of the exact fixed-ratio formulation remains the next necessary step.
Zitieren
APA
Yassine, J., Semenza, G. L., & Bishop, A. (2026). Clinical Evaluation of an NVTIA 5-HTP-L-Theanine-GABA Sleep Rhythm Support System. Scientific Journal of Technology, 8(4), 256-261. https://doi.org/10.54691/wa60tw61
Vancouver
Yassine J, Semenza GL, Bishop A. Clinical Evaluation of an NVTIA 5-HTP-L-Theanine-GABA Sleep Rhythm Support System. Scientific Journal of Technology. 2026;8(4):256-261. doi:10.54691/wa60tw61
BibTeX
@article{Yassine2026,
author = {Yassine, Jabar and Semenza, Gregg L. and Bishop, Andre},
title = {Clinical Evaluation of an NVTIA 5-HTP-L-Theanine-GABA Sleep Rhythm Support System},
journal = {Scientific Journal of Technology},
year = {2026},
volume = {8},
number = {4},
pages = {256--261},
doi = {10.54691/wa60tw61}
}
EUVIMED